These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 122655)

  • 1. Effect of penicillamine on the kidney.
    Davison AM; Day AT; Golding JR; Thomson D
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):109-13. PubMed ID: 122655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.
    Bacon PA; Tribe CR; Mackenzie JC; Verrier-Jones J; Cumming RH; Amer B
    Q J Med; 1976 Oct; 45(180):661-84. PubMed ID: 1005658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathology of penicillamine-induced glomerular disease.
    Dische FE; Swinson DR; Hamilton EB; Parsons V
    J Rheumatol; 1976 Jun; 3(2):145-54. PubMed ID: 950631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinuria in D-penicillamine-treated rheumatoid arthritis.
    Crawhall JC
    J Rheumatol Suppl; 1981; 7():161-3. PubMed ID: 6939879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathology of penicillamine-induced glomerular disease.
    Dische FE; Swinson DR; Hamilton EB; Parsons V
    J Rheumatol; 1984 Oct; 11(5):584-5. PubMed ID: 6392549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term aurothiomalate and D-penicillamine treatments on renal function and urinary excretion of prostanoids in patients with rheumatoid arthritis.
    Seppälä E; Lehtinen K; Isomäki H; Nissilä M; Harmoinen A; Mörsky P; Koivula T; Vapaatalo H
    Int J Clin Pharmacol Res; 1988; 8(3):149-56. PubMed ID: 3136089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Glomerulopathy in rheumatic patients due to penicillamine].
    Muller V; Krumhaar I; Schneider W; Ditscherlein G
    Allerg Immunol (Leipz); 1976; 22(3):291-5. PubMed ID: 139094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathological study of nephropathy in patients with rheumatoid arthritis].
    Yoshida A; Morozumi K; Suganuma T; Aoki J; Sugito K; Koyama K; Oikawa T; Fujinimi T; Matsumoto Y
    Ryumachi; 1991 Feb; 31(1):14-21. PubMed ID: 1677490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural course of gold and penicillamine nephropathy: a longterm study of 54 patients.
    Hall CL
    Adv Exp Med Biol; 1989; 252():247-56. PubMed ID: 2782197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Undesirable effects of D-penicillamine in the therapy of rheumatoid arthritis].
    Trnavský K; Zbojanová M
    Fysiatr Revmatol Vestn; 1979 Apr; 57(2):87-91. PubMed ID: 570949
    [No Abstract]   [Full Text] [Related]  

  • 12. [Early recognition of adverse effects, especially of kidney lesions, in patients with progressive chronic polyarthritis under D-Penicillamine therapy].
    Otto W; Pietruschka WD; Beenken O
    Z Gesamte Inn Med; 1975 Aug; 30(15):507-9. PubMed ID: 1189496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural course of penicillamine nephropathy: a long term study of 33 patients.
    Hall CL; Jawad S; Harrison PR; MacKenzie JC; Bacon PA; Klouda PT; MacIver AG
    Br Med J (Clin Res Ed); 1988 Apr; 296(6629):1083-6. PubMed ID: 3132218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Control of penicillamine therapy in patients with chronic polyarthritis through urine disc electrophoresis].
    Rautenstrauch H
    Z Rheumatol; 1977; 36(11-12):356-63. PubMed ID: 595910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine.
    Domljan Z; Borso G; Marinković M; Winter Fudurić I; Pucar I; Cikes N
    Acta Med Iugosl; 1987; 41(5):363-72. PubMed ID: 3128058
    [No Abstract]   [Full Text] [Related]  

  • 16. Penicillamine nephropathy.
    Ross JH; McGinty F; Brewer DG
    Nephron; 1980; 26(4):184-6. PubMed ID: 7432580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morphology and pathogenesis of penicillamine-induced nephropathy].
    Henzgen S; Waldmann G
    Zentralbl Allg Pathol; 1983; 128(1-2):53-61. PubMed ID: 6637187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longterm low dose cyclosporine in patients with rheumatoid arthritis: renal function loss without structural nephropathy.
    Landewé RB; Dijkmans BA; van der Woude FJ; Breedveld FC; Mihatsch MJ; Bruijn JA
    J Rheumatol; 1996 Jan; 23(1):61-4. PubMed ID: 8838509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is myositis in chronic polyarthritis using d-penicillamine drug-induced?].
    Schlumpf U; Bussmann HU; Jerusalem F
    Schweiz Med Wochenschr; 1981 Jan; 111(1):29-35. PubMed ID: 6782670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glomerulopathy due to D-penicillamine--clinical findings and renal biopsy].
    Brass H; Genth E; Hartl PW; Bauerdick H; Buss H; Lapp H; Heintz R
    Med Welt; 1976 Nov; 27(45):2151-3. PubMed ID: 994834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.